Dr. Brian Gastman, MD
Claim this profileCleveland Clinic
Studies Melanoma
Studies Skin Cancer
10 reported clinical trials
13 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
Stage II
2Skin Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Brian Gastman, MD is currently running
AdAPT-001
for Cancer
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Recruiting1 award Phase 217 criteria
APG-115 + Pembrolizumab
for Skin Cancer
This study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of APG-115, an MDM2 inhibitor, either alone or in combination with pembrolizumab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of the immune response concomitant to inhibition of the MDM2 pathway (which restores p53 functions) may promote cancer cell death, leading to effective anticancer therapy.
Recruiting1 award Phase 1 & 213 criteria
More about Brian Gastman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Brian Gastman, MD has experience with
- Pembrolizumab
- Nivolumab
- Relatlimab
- Placebo
- CtDNA Analysis
- Nivolumab + Relatlimab Fixed-dose Combination (FDC)
Breakdown of trials Brian Gastman, MD has run
Melanoma
Skin Cancer
Basal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Gastman, MD specialize in?
Brian Gastman, MD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Brian Gastman, MD currently recruiting for clinical trials?
Yes, Brian Gastman, MD is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Brian Gastman, MD has studied deeply?
Yes, Brian Gastman, MD has studied treatments such as Pembrolizumab, Nivolumab, Relatlimab.
What is the best way to schedule an appointment with Brian Gastman, MD?
Apply for one of the trials that Brian Gastman, MD is conducting.
What is the office address of Brian Gastman, MD?
The office of Brian Gastman, MD is located at: Cleveland Clinic, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.